EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD

Nantawat Satthawiwat iD, Thananya Jinato, Sawannee Sutheeworapong, Natthaporn Tanpowpong iD, Natthaya Chuaypen iD, Pisit Tangkijvanich iD

Nutrients · 2024

DOI: 10.3390/nu16121800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Nantawat Satthawiwat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailan…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Cirrhosis, Severity of Illness Index, Membrane Proteins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B), National Research Council of Thailand (NRCT), Second Century Fund (C2F).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota might affect the severity and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to characterize gut dysbiosis and clinical parameters regarding fibrosis stages assessed by magnetic resonance elastography. This study included 156 patients with MASLD, stratified into no/mild fibrosis (F0–F1) and moderate/severe fibrosis (F2–F4). Fecal specimens were sequenced targeting the V4 region of the 16S rRNA gene and analyzed using bioinformatics. The genotyping of PNPLA3, TM6SF2, and HSD17B13 was assessed by allelic discrimination assays. Our data showed that gut microbial profiles between groups significantly differed in beta-diversity but not in alpha-diversity indices. Enriched Fusobacterium and Escherichia_Shigella, and depleted Lachnospira were found in the F2–F4 group versus the F0–F1 group. Compared to F0–F1, the F2–F4 group had elevated plasma surrogate markers of gut epithelial permeability and bacterial translocation. The bacterial genera, PNPLA3 polymorphisms, old age, and diabetes were independently associated with advanced fibrosis in multivariable analyses. Using the Random Forest classifier, the gut microbial signature of three genera could differentiate the groups with high diagnostic accuracy (AUC of 0.93). These results indicated that the imbalance of enriched pathogenic genera and decreased beneficial bacteria, in association with several clinical and genetic factors, were potential contributors to the pathogenesis and progression of MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLiver CirrhosisSeverity of Illness IndexMembrane ProteinsHumansFemaleMaleMiddle AgedLipaseAgedRNA, Ribosomal, 16SDysbiosisFatty LiverFecesAdultGenetic VariationElasticity Imaging TechniquesBacteriaAcyltransferases17-Hydroxysteroid DehydrogenasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

fibrosisgut microbiotamagnetic resonance elastography (MRE)metabolic dysfunction-associated steatotic liver disease (MASLD)

Substanzen

Membrane ProteinsTM6SF2 protein, humanLipasePNPLA3 protein, humanRNA, Ribosomal, 16SHSD17B13 protein, humanAcyltransferases17-Hydroxysteroid DehydrogenasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Doctor of Philosophy Program in Medical Biochemistry, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Systems Biology and Bioinformatics Research Unit, Pilot Plant Development and Training Institute, King Mongkut's University of Technology Thonburi, Bangkok 10150, Thailand.
  • Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.

ORCID-Profile: Nantawat Satthawiwat, Natthaporn Tanpowpong, Natthaya Chuaypen, Pisit Tangkijvanich

Förderung

  • Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B)
  • National Research Council of Thailand (NRCT)
  • Second Century Fund (C2F)
  • Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University
  • Program Management Unit for Human Resources & Institutional Development, Research and Innovation
  • Second Century Fund (C2F), Chulalongkorn University

Zitieren

APA

Satthawiwat, N., Jinato, T., Sutheeworapong, S., Tanpowpong, N., Chuaypen, N., & Tangkijvanich, P. (2024). Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients. https://doi.org/10.3390/nu16121800

Vancouver

Satthawiwat N, Jinato T, Sutheeworapong S, Tanpowpong N, Chuaypen N, Tangkijvanich P. Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients. 2024. doi:10.3390/nu16121800

BibTeX
@article{Satthawiwat2024,
  author = {Satthawiwat, Nantawat and Jinato, Thananya and Sutheeworapong, Sawannee and Tanpowpong, Natthaporn and Chuaypen, Natthaya and Tangkijvanich, Pisit},
  title = {Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16121800}
}
Kostenlos starten →